A detailed history of American Century Companies Inc transactions in Pyxis Oncology, Inc. stock. As of the latest transaction made, American Century Companies Inc holds 159,439 shares of PYXS stock, worth $269,451. This represents 0.0% of its overall portfolio holdings.

Number of Shares
159,439
Previous 58,252 173.71%
Holding current value
$269,451
Previous $192,000 204.69%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$2.83 - $3.94 $286,359 - $398,676
101,187 Added 173.71%
159,439 $585,000
Q2 2024

Aug 07, 2024

BUY
$3.06 - $5.58 $63,957 - $116,627
20,901 Added 55.96%
58,252 $192,000
Q1 2024

May 14, 2024

BUY
$2.03 - $6.59 $47,867 - $155,392
23,580 Added 171.23%
37,351 $159,000
Q4 2023

Feb 13, 2024

BUY
$1.4 - $2.09 $19,279 - $28,781
13,771 New
13,771 $24,000
Q3 2023

Nov 13, 2023

BUY
$1.6 - $2.78 $22,033 - $38,283
13,771 New
13,771 $27,000

Others Institutions Holding PYXS

About Pyxis Oncology, Inc.


  • Ticker PYXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,096,400
  • Market Cap $59.3M
  • Description
  • Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, engages in the development of therapies to treat cancers. Its immune-oncology product candidates include PYX-106, an investigational fully human immunoglobulin G1 isotype siglec-15 targeting antibody for the treatment of thyroid cancer, head and neck squamous cell carcinoma, no...
More about PYXS
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.